These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36222504)

  • 21. IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
    Chiang S; Weigelt B; Wen HC; Pareja F; Raghavendra A; Martelotto LG; Burke KA; Basili T; Li A; Geyer FC; Piscuoglio S; Ng CK; Jungbluth AA; Balss J; Pusch S; Baker GM; Cole KS; von Deimling A; Batten JM; Marotti JD; Soh HC; McCalip BL; Serrano J; Lim RS; Siziopikou KP; Lu S; Liu X; Hammour T; Brogi E; Snuderl M; Iafrate AJ; Reis-Filho JS; Schnitt SJ
    Cancer Res; 2016 Dec; 76(24):7118-7129. PubMed ID: 27913435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy for isocitrate dehydrogenase 2 (IDH2)
    Linch DC; Hills RK; Burnett AK; Russell N; Gale RE
    Br J Haematol; 2022 Mar; 196(6):1348-1352. PubMed ID: 34870324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.
    Glöss S; Jurmeister P; Thieme A; Schmid S; Cai WY; Serrette RN; Perner S; Ribbat-Idel J; Pagenstecher A; Bläker H; Keber U; Stadelmann C; Zechel S; Johann PD; Hasselblatt M; Paulus W; Thomas C; Dohmen H; Baumhoer D; Frank S; Agaimy A; Schüller U; Vasudevaraja V; Snuderl M; Liu CZ; Pfister DG; Jungbluth AA; Ghossein RA; Xu B; Capper D; Dogan S
    Am J Surg Pathol; 2021 Sep; 45(9):1190-1204. PubMed ID: 34265800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
    Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
    Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma.
    Liu X; Ogasawara S; Kaneko MK; Oki H; Hozumi Y; Goto K; Takagi M; Kato Y
    Biochem Biophys Res Commun; 2015 Apr; 459(4):636-42. PubMed ID: 25753205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone.
    Kato Kaneko M; Liu X; Oki H; Ogasawara S; Nakamura T; Saidoh N; Tsujimoto Y; Matsuyama Y; Uruno A; Sugawara M; Tsuchiya T; Yamakawa M; Yamamoto M; Takagi M; Kato Y
    Cancer Sci; 2014 Jun; 105(6):744-8. PubMed ID: 24898068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.
    Kato Kaneko M; Ogasawara S; Kato Y
    Tohoku J Exp Med; 2013 Jun; 230(2):103-9. PubMed ID: 23782684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.
    Kato Y
    Brain Tumor Pathol; 2015 Jan; 32(1):3-11. PubMed ID: 25324168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development.
    Lemonnier F; Cairns RA; Inoue S; Li WY; Dupuy A; Broutin S; Martin N; Fataccioli V; Pelletier R; Wakeham A; Snow BE; de Leval L; Pujals A; Haioun C; Paci A; Tobin ER; Narayanaswamy R; Yen K; Jin S; Gaulard P; Mak TW
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15084-15089. PubMed ID: 27956631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.
    Dupuy A; Lemonnier F; Fataccioli V; Martin-Garcia N; Robe C; Pelletier R; Poullot E; Moktefi A; Mokhtari K; Rousselet MC; Traverse-Glehen A; Delarue R; Tournilhac O; Delfau-Larue MH; Haioun C; Ortonne N; Copie-Bergman C; de Leval L; Pujals A; Gaulard P
    J Mol Diagn; 2018 Sep; 20(5):677-685. PubMed ID: 29981867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent IDH2 Mutations in Salivary Gland Striated Duct Adenoma Define an Expanded Histologic Spectrum Distinct From Canalicular Adenoma.
    Rooper LM; Agaimy A; Assaad A; Bal M; Eugene H; Gagan J; Nonogaki H; Palsgrove DN; Shah A; Stelow E; Stoehr R; Thompson LDR; Weinreb I; Bishop JA
    Am J Surg Pathol; 2023 Mar; 47(3):333-343. PubMed ID: 36510691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a novel monoclonal antibody WMab-1 specific for IDH2-R172W mutation.
    Kato Y; Kaneko MK
    Biochem Biophys Res Commun; 2013 Apr; 433(4):374-8. PubMed ID: 23524262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.
    Das BR; Tangri R; Ahmad F; Roy A; Patole K
    Asian Pac J Cancer Prev; 2013; 14(12):7261-4. PubMed ID: 24460285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.
    Green CL; Evans CM; Zhao L; Hills RK; Burnett AK; Linch DC; Gale RE
    Blood; 2011 Jul; 118(2):409-12. PubMed ID: 21596855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cancer-associated point mutations on the structure, function, and stability of isocitrate dehydrogenase 2.
    Chen X; Yang P; Qiao Y; Ye F; Wang Z; Xu M; Han X; Song L; Wu Y; Ou WB
    Sci Rep; 2022 Nov; 12(1):18830. PubMed ID: 36335201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report: Tall cell carcinoma with reversed polarity of the breast: an additional case and review of the literature.
    Lei Z; Wang YX; Wang ZY; Yang CG; Pan GQ
    Front Oncol; 2024; 14():1302196. PubMed ID: 38434689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining IDH-Mutational Status in Gliomas Using IDH1-R132H Antibody and Polymerase Chain Reaction.
    Gondim DD; Gener MA; Curless KL; Cohen-Gadol AA; Hattab EM; Cheng L
    Appl Immunohistochem Mol Morphol; 2019; 27(10):722-725. PubMed ID: 30358614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.
    Jin G; Reitman ZJ; Spasojevic I; Batinic-Haberle I; Yang J; Schmidt-Kittler O; Bigner DD; Yan H
    PLoS One; 2011 Feb; 6(2):e16812. PubMed ID: 21326614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers.
    Raynaud S; Carbuccia N; Colin C; Adélaïde J; Mozziconacci MJ; Metellus P; Chinot O; Birnbaum D; Chaffanet M; Figarella-Branger D
    Oncol Lett; 2010 Sep; 1(5):883-884. PubMed ID: 22966399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations.
    Kaneko MK; Morita S; Tsujimoto Y; Yanagiya R; Nasu K; Sasaki H; Hozumi Y; Goto K; Natsume A; Watanabe M; Kumabe T; Takano S; Kato Y
    Biochem Biophys Res Commun; 2013 Mar; 432(1):40-5. PubMed ID: 23376717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.